CALL: TEVA PHARMACEUTICAL INDUSTRIES JUN 24 EXP 06/15/18

Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CALL: TEVA PHARMACEUTICAL INDUSTRIES JUN 24 EXP 06/15/18 Equity Options, CUSIP 881624M8F.